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Age related differences in CPAP levels for sleep apnea 1217Introduction
The prevalence of sleep-disordered breathing is
greater in the elderly.1,2 Continuous positive airway
pressure (CPAP) is the standard treatment for
obstructive sleep apnea, in both elderly and young
patients. Aging has been associated with lower
adherence to CPAP therapy in some3 but not all4
studies; suggesting that age may be an important
inclusion factor when setting CPAP levels in the
elderly.
The level of CPAP required for the effective
management of sleep apnea is optimally assessed
with a CPAP titration study.5 However, the increas-
ing demand for treatment of sleep apnea has led to
the development of algorithms for the prediction of
therapeutic CPAP levels. These algorithms use
factors such as disease severity, (apnea/hypopnea
index AHI) body mass index (BMI) and neck
circumference6,7; until recently, age has not been
considered as an important factor.8 Indeed, age was
not included in the formula adopted by a recent
large multicenter study, carried out to determine
whether CPAP titration preformed using unat-
tended auto adjusting CPAP or a predictive formula,
was as effective as titration carried out in a sleep
laboratory using full polysomnography.9
Elderly subjects without sleep apnea have a
greater sleep-related increase in upper airway
resistance (UAR) compared to younger sub-
jects.10,11 Yet, in a previous study we observed
that, compared to young subjects, elderly subjects
required a similar level of CPAP to control for their
greater sleep-related increase in UAR.12 This
finding led us to the hypothesis that, for a given
severity of sleep apnea, elderly apneic patients
might require lower CPAP levels than younger
apneics.
CPAP abolishes upper airway obstruction by
acting as a ‘‘pneumatic splint’’ that increases
upper airway cross-sectional area during inspira-
tion13 and during the progressive narrowing of the
lumen that occurs during expiration.14 In addition,
CPAP increases end expiratory lung volume
(EELV).15 These responses may have a different
impact in the elderly compared to young sleep
apneic patients. Upper airway cross-sectional area
has been shown to be lung volume-dependent, with
an increase from residual volume to total lung
capacity in young people during wakefulness.16
Likewise during sleep, reduced lung volumes
increase upper airway collapsibility and inspiratory
airflow resistance in young people.17 In the elderly,
changes in respiratory mechanics, reflecting de-
creases in lung elastic recoil and chest wall
compliance,18 may have an impact on the contribu-tion of lung inflation to the overall action of CPAP in
determining upper airway cross-sectional area.
The first aim of our study was to investigate
whether elderly patients with sleep apnea would
require lower therapeutic levels of CPAP, compared
with a group of young apneic patients, matched for
AHI, BMI and neck circumference. The second aim
of our study was to investigate the influence of age
on the relative contribution of the two mechanisms
produced by CPAP, i.e. the direct ‘‘splinting’’ effect
and the indirect impact of lung inflation on UAR. In
order to distinguish these two mechanisms, we
applied separately CPAP and its components (in-
spiratory positive airway pressure [IPAP] and
expiratory airway pressure [EPAP]) in two groups
of elderly and young patients with sleep apnea
during wakefulness. IPAP was used to provide a
‘‘splinting’’ positive airway pressure without a
substantial effect on lung volume and EPAP was
used to increase lung volume. We tested the
hypothesis that elderly patients would have a
greater decrease in UAR with the application of
the same level of CPAP, with both mechanisms
contributing to this difference.Methods
Assessment of therapeutic CPAP levels in
elderly and young
Subjects
Subject characteristics are presented in Table 1.
Two groups of seventy elderly and seventy young
sleep apneic patients, matched for AHI, BMI and
neck circumference, were consecutively recruited
from our sleep laboratory, based on the presence of
sleep apnea (AHIX10 events/h on diagnostic sleep
study) and a successful CPAP titration study
(reduction of AHI to o10 events/h). All subjects
were otherwise healthy and had normal spirometry.Measurements
Sleep apnea severity was determined from diag-
nostic sleep studies, obtained from a commercial
system (EdenTrace II digital recorder, Nellcore
Puritan Bennett, Pleasanton, CA). Levels of CPAP
required to reverse sleep apnea were determined
from an unattended titration study, using a com-
mercial system (AutoSet portable II Plus, Resmed,
Poway, CA). The 95th percentile CPAP value was
considered as optimal therapeutic pressure for
each patient.19
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Table 2 Characteristics of the elderly and young patients with sleep apnea participating in the application of
CPAP, IPAP and EPAP study.
Elderly (n ¼ 9) Young (n ¼ 9) P-value
Gender (male/female) 8/1 9/0
Age (yr) 71.7 (3.3) 36.7 (4.4) o0.0001
BMI (kg/m2) 28.5 (2.9) 29.3 (4.4) 0.60
Neck circumference (cm) 43 (3.2) 43 (2.9) 1.00
AHI—diagnostic study (events/h) 38.3 (19.6) 38.1 (28.2) 0.86
Data are presented as mean (SD).
BMI ¼ body mass index, AHI ¼ apnea–hypopnea index.
Table 1 Characteristics of elderly and young patients with sleep apnea studied for the assessment of
therapeutic CPAP levels.
Elderly (n ¼ 70) Young (n ¼ 70) P-value
Gender (male/female) 66/4 67/3
Age (yr) 68.1 (3.6) 34.7 (4.1) o0.0001
BMI (kg/m2) 30.9 (6.2) 31.6 (5.4) 0.18
Neck circumference (cm) 43 (2.8) 43 (3.3) 0.41
AHI—diagnostic study (events/h) 30.5 (15.7) 28.4 (18.2) 0.17
AHI—titration study (events/h) 3.5 (2.4) 3.6 (2.7) 0.84
Data are presented as mean (SD).
BMI ¼ body mass index, AHI ¼ apnea–hypopnea index.
K. Kostikas et al.1218Positive airway pressure-related changes in
UAR and lung volume
Subjects
Subject characteristics are presented in Table 2.
Nine elderly and nine young patients with sleep
apnea (AHIX10 events/h) were recruited from
patients attending our sleep laboratory. All patients
were otherwise healthy and had normal spirometry.
No patients took part in both studies.Application of CPAP, IPAP and EPAP
During the protocol the patients were awake,
breathing via a full-face mask (Respironics, Pitts-
burgh, PA) connected to a pneumotachometer
(Model 3700A, Hans Rudolph Inc., Kansas City,
MO). CPAP, IPAP and EPAP were separately applied
in a random order. CPAP and IPAP were supplied by a
commercially available ventilator (BiPAP Harmo-
nyTM S/T; Respironics, Pittsburgh, PA) connected to
the full-face mask via a length of tubing. The
ventilator was set to deliver either CPAP, or the
required level of IPAP when triggered by the
patient’s inspiration. For the application of EPAP,
a T-shaped two-way unidirectional valve (Model
2600, Hans Rudolph Inc, Kansas City, MO) was
attached to the pneumotachometer. EPAP was
applied with a commercial valve (Whisperflow CPAPvalve; Medic-Aid, Bognor Regis, UK) connected to
the expiratory limb of the unidirectional valve.
Measurements
Respiratory parameters were assessed using meth-
odology and equipment that has been previously
described.12 In brief, airflow was measured by the
pneumotachometer, coupled to a differential pres-
sure transducer (MP45; Validyne, Northridge, CA,
USA). Ribcage and abdominal movements were
monitored using calibrated, DC-coupled, respira-
tory inductance plethysmography (RIP; RespitraceR,
Ambulatory Monitoring, Arsley, NY).20 These re-
cordings were used for the assessment of shifts in
EELV.
Total pulmonary resistance (RL; lung tissue
resistance plus airway resistance, including the
upper airway) was assessed from the airflow and
pleural pressure values.12 An index of pleural
pressure was provided from measurements of the
esophageal pressure, obtained from an esophageal
catheter with a pressure transducer (CTC/6F;
Gaeltec, Scotland, UK). The airflow and esophageal
pressure signals were continuously recorded using
commercial software (Spike 2, Cambridge Electro-
nic Design Ltd, Cambridge, UK) to provide a
continuous on-line value of RL; for each breath
the signal was divided into eleven equal sections,
the middle seven of which were averaged to
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Age related differences in CPAP levels for sleep apnea 1219provide the RL measurement for the breath. The
changes in this value were used as an index of
changes in UAR.12,20Protocol details
Medical history was obtained from the patients,
and clinical examination and spirometry were
performed. Then, the esophageal catheter was
inserted and the RIP bands were fitted and
calibrated with subjects in the supine position.20
Subsequently, the face mask was fitted, the
pneumotachometer was attached and a check was
made for air leaks around the mask. The subjects
were given time to familiarize themselves with
each of the pressures: CPAP, IPAP and EPAP. When
they felt comfortable, all three pressures were
applied in a randomized order. For each condition,
following 2–4min of resting breathing, positive
airway pressure was applied at 10 cm H2O for a
further 2min. All measurements were made during
the last minute of each 2min period. Throughout
this procedure subjects were awake. The local
ethics committee approved the protocol and sub-
jects gave written informed consent.Statistical analysis
Data are presented as mean (SD). Comparisons
between groups were made with paired t-tests or
Mann–Whitney U tests, when data were normally or
not normally distributed, respectively. The effects
of CPAP, IPAP and EPAP on respiratory variables
between elderly and young groups were assessed
with two-way analysis of variance, using ‘‘age’’
(elderly and young) as a between factor and
‘‘positive airway pressure’’ (resting breathing and
pressure of 10 cm H2O) as a within factor. Statistical
significance was defined as Pp0:05.Pm
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during wakefulness. Notice the greater changes in EELV induce
subject. The difference between the effects of IPAP on
Pmask ¼ mask pressure. Ribcage and abdominal movementsResults
Assessment of therapeutic CPAP levels in
elderly and young
Elderly patients with sleep apnea required signifi-
cantly lower levels of CPAP than young ones
[6.9(1.9) cm H2O and 9.4(3.5) cm H2O, respectively;
Po0:0001]. There were no significant differences in
BMI, neck circumference or AHI in the diagnostic
sleep study between the two groups. Moreover, the
AHI measured during the titration study did not
differ between the two groups (Table 1).Positive airway pressure-related changes in
UAR and lung volume
There were no significant differences in BMI, neck
circumference, and AHI between the young and
elderly sleep apneic patients studied (Table 2). A
typical recording of an elderly and a young patient
with sleep apnea during the application of CPAP,
IPAP and EPAP is shown in Fig. 1.Positive airway pressure-related changes
in RL
The RL before and after the application of CPAP,
IPAP and EPAP are presented in Table 3. Changes in
RL are presented in Fig. 2. (A) The application of
CPAP produced a significant reduction in RL
(expressed as % of the resting value) both in the
elderly [61(12)%, Po0:0001] and the young [74(6)%,
Po0:0001]. The magnitude of reduction was great-
er in the elderly compared to the young patients
(P ¼ 0:009, F ¼ 7:667). (B) IPAP also produced a
significant reduction in RL, both in the elderly
[68(9)%, Po0:0001] and the young [82(7)%,O Resting 10 cmH2O 
CPAP
10 cmH2O
IPAP
10 cmH2O
EPAP
Resting Resting
Young
t with sleep apnea during the application of continuous
pressure (IPAP) and expiratory airway pressure (EPAP)
d by CPAP and EPAP in the elderly compared to the young
EELV compared to CPAP and EPAP is also prominent.
are displayed in ml.
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Table 3 Values of total pulmonary resistance (RL, in cm H2O/l/s) for elderly and young patients with sleep
apnea, during resting breathing and with the application of CPAP, IPAP and EPAP at a pressure of 10 cm H2O.
Resting breathing 10 cm H2O
CPAP Elderly 8.20 (2.36) 5.06 (1.77)
Young 7.82 (3.43) 5.75 (2.50)
IPAP Elderly 8.05 (3.57) 5.57 (2.48)
Young 8.24 (3.23) 6.67 (2.50)
EPAP Elderly 9.56 (2.90) 8.44 (2.46)
Young 9.30 (3.17) 8.91 (3.09)
Data are presented as mean (SD).
CPAP ¼ continuous positive airway pressure, IPAP ¼ inspiratory positive airway pressure, EPAP ¼ expiratory positive airway
pressure.
K. Kostikas et al.1220Po0:0001]. The magnitude of reduction was great-
er in the elderly (P ¼ 0:02, F ¼ 6:215). (C) EPAP
produced a smaller, but statistically significant,
reduction in RL, both in the elderly [89(6)%,
P ¼ 0:0006] and the young [96(2)%, P ¼ 0:0007].
Again, the magnitude of reduction was greater in
the elderly (P ¼ 0:003, F ¼ 10:322).
In both groups, the application of CPAP induced
greater reductions in RL compared to the applica-
tion of IPAP alone (elderly: P ¼ 0:05; young:
P ¼ 0:02) or EPAP alone (elderly: Po0:0001; young
Po0:0001). IPAP also caused greater reductions
in RL than EPAP (elderly: Po0:0001; young
Po0:0001).Positive airway pressure-related changes in
EELV
Changes in EELV during the application of CPAP, IPAP
and EPAP are shown in Fig. 3. (A) The application of
CPAP produced a significant increase in lung volume
from the resting level, both in elderly [839
(258)ml, Po0:0001] and young patients [544
(173)ml, Po0:0001]. The magnitude of this increase
was greater in the elderly (P ¼ 0:008, F ¼ 8:147).
(B) IPAP produced a minimal, but statistically
significant, increase in lung volume from the resting
level, both in elderly [42 (43)ml, P ¼ 0:02] and
young [38 (29)ml, P ¼ 0:005]. However, the magni-
tude of the increase did not differ between the two
groups (P ¼ 0:81, F ¼ 0:06). (C) EPAP was also
associated with a significant increase in lung
volume from the resting level, both in the elderly
[892 (279)ml, Po0:0001] and the young [530
(185)ml, Po0:0001]. In this case, the magnitude
of the increase was greater in the elderly
(P ¼ 0:003, F ¼ 10:322).
In both groups, the application of CPAP caused
significantly greater increases in lung volume thanIPAP alone (Po0:0001, for both groups). Similarly,
EPAP produced significantly greater increases in
lung volume than IPAP (Po0:0001, for both groups).
However, the increases in lung volume associated
with the application of CPAP and EPAP were not
significantly different in either group (elderly:
P ¼ 0:79; young: P ¼ 0:82).Discussion
In this study we found that the required CPAP levels
for effective treatment of sleep apnea were
significantly lower in a population of elderly
compared to a matched group of young patients.
We suggest that the greater effects of CPAP in the
elderly may be attributed to both (a) the greater
direct splinting of the upper airway and (b) the
greater indirect reduction of UAR due to a larger
degree of lung inflation.
Our findings may be beneficial for developing
improved treatment for sleep apnea in the elderly,
particularly due to the fact that the risk of
discontinuing CPAP due to nasal and pharyngeal
side-effects increases with age.3 Such side effects
might well be attributed to higher than necessary
CPAP levels. Given the increasing demand for the
treatment of obstructive sleep apnea24 our findings
indicate that care must be taken when prescribing
CPAP levels in elderly patients.
Various parameters have been found to influence
the effective therapeutic CPAP levels, the most
significant being BMI, neck circumference and sleep
apnea severity (AHI), accounting for 76% of the
variability of effective CPAP levels.6 Several algo-
rithms have been proposed for the prediction of
effective CPAP which incorporate these para-
meters7,8,21; they have been found to be accurate
in approximately 14%22 and 22%7 of patients with
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Elderly
40
60
80
100
40
60
80
100
Positive airway pressure
(cmH2O)
R
L 
(%
 re
sti
ng
)
R
L 
(%
 re
sti
ng
)
R
L 
(%
 re
sti
ng
)
40
60
80
100
Young
40
60
80
100
40
60
80
100
Positive airway pressure
(cmH2O)
0 10
40
60
80
100
CPAP
IPAP
EPAP
50 105
(A)
(B)
(C)
Figure 2 Individual subject (open squares) and group mean (filled squares) measurements of total pulmonary resistance
(RL), during quiet resting breathing and with the application of positive airway pressure, in the two groups of elderly
(n ¼ 9) and young (n ¼ 9) patients with sleep apnea. RL values during the application of positive airway pressure are
expressed as % of resting values. The graphs represent measurements with the application of (A) continuous positive
airway pressure (CPAP) of 10 cm H2O, (B) inspiratory positive airway pressure (IPAP) of 10 cm H2O, and (C) expiratory
positive airway pressure (EPAP) of 10 cm H2O.
Age related differences in CPAP levels for sleep apnea 1221obstructive sleep apnea. In another study, CPAP
levels were strongly correlated with BMI, AHI, UAR
and pharyngeal critical pressure,23 and in this case
these variables accounted for 36% of the variability
in CPAP levels. In all these studies age was not
found to be a significant determinant of therapeu-
tic CPAP levels. The difference between thefindings of our study and the previous ones may
be due to the selection of our patients. Our
patients were divided into two groups of elderly
(65–77 years) and young (21–40 years) patients,
specifically matched for the most important fac-
tors.6 In this way, the difference of the required
CPAP levels observed between the two groups may
ARTICLE IN PRESS
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Figure 3 Individual subject (open squares) and group mean (filled squares) changes in end-expiratory lung volume
(EELV), during quiet resting breathing and with the application of positive airway pressure, in the two groups of elderly
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K. Kostikas et al.1222be attributed, at least partially, to the difference
in age.Positive airway pressure-related changes in
UAR and lung volume
In order to clarify the mechanisms underlying the
age-related differences in CPAP levels, the secondaim of our study focused on the effects of CPAP on
UAR and lung volume in elderly and young patients
with sleep apnea. Accordingly, we studied the
changes in RL (as a measure of changes in UAR)
and in lung volume (EELV) after the application of
CPAP and its components, IPAP and EPAP. IPAP
provided a ‘‘splinting’’ positive airway pressure
without significant increase in EELV, whereas EPAP
was used to increase EELV without significant
ARTICLE IN PRESS
Age related differences in CPAP levels for sleep apnea 1223‘‘splinting’’ of the upper airway during inspiration.
Consistent with the findings of our first aim, the
elderly apneic patients had greater reductions of
UAR during the application of CPAP compared to
the young. The reductions in UAR with CPAP were
greater than those achieved with IPAP, suggesting
an additional role of EPAP in the reduction of UAR.
Furthermore, the application of CPAP resulted in an
increase in EELV, which again was more prominent
in the elderly. This CPAP-induced increase in EELV
could be mainly attributed to the effect of EPAP, as
IPAP caused only a minimal increase in EELV in both
age groups. It therefore seems likely that, in
patients with sleep apnea, CPAP increases upper
airway cross-sectional area both directly through
its ‘‘splinting’’ effect and indirectly through an
increase in lung volume. Interestingly, both these
effects are more prominent in the elderly.
The reductions of UAR with the application of
CPAP in sleep apnea are consistent with previous
studies that reported a CPAP-induced increase of
the pharyngeal cross-sectional area during wake-
fulness, in both apneic and non-apneic subjects.13
Positive airway pressure has been reported to
modify upper airway dilator muscle activity during
wakefulness25 and sleep,26 indirectly distending the
upper airway. The application of IPAP also resulted
in UAR reductions in both elderly and young apneic
patients, although these were minor compared to
CPAP. These findings are in agreement with those of
Series et al., who reported reductions in pharyn-
geal resistance during wakefulness, when a combi-
nation of CPAP and positive extrathoracic pressure
(i.e. CPAP without lung inflation) were applied to
normal young subjects.27 A plausible explanation
for the greater reduction in total pulmonary
resistance during the application of CPAP or IPAP
that we observed in our elderly patients could be
the increase in pharyngeal compliance that has
been observed with aging.28
Both CPAP and EPAP produced greater increases
in lung volume in the elderly, which could be
attributed to age-related changes in thoracic
compliance.18 The application of EPAP resulted in
smaller but significant reductions in UAR, in both
elderly and young. These reductions might be
attributed to the EPAP-induced increase in lung
volume, in accordance with previous investigators
reporting that the pharyngeal cross-sectional area
in patients with sleep apnea during wakefulness is
lung volume-dependent16 and that UAR collapsi-
bility is increased during NREM sleep at reduced
lung volume.17
The underlying mechanism for the reduction of
UAR during increases in lung volume may be the
caudal traction of upper airway structures, due tothe descent of the diaphragm and the increased
negative intrathoracic pressure observed at end-
expiration.29 The indirect reduction of UAR due to
the increase in end-expiratory lung volume pro-
duced by EPAP may account for the greater
reduction of UAR produced by CPAP compared to
IPAP in our study. Our results support the previously
reported important role of EPAP in the treatment of
patients with obstructive sleep apnea.30Limitations
In the present study there are a number of
limitations. First, we assumed that differences in
total pulmonary resistance could be attributed to
the reduction of UAR. Previous studies report that
UAR accounts for the greatest part of total
pulmonary resistance during sleep.12,20,31 More-
over, the reduction in total lung resistance asso-
ciated with lung inflation has been correlated with
a reduction in UAR both in wakefulness and sleep.32
Therefore, in the present study, it was reasoned
that differences in total lung resistance would
provide an accurate index of differences in UAR,
and that meaningful data could be obtained during
wakefulness. However, it must be noted that all of
the above studies have been carried out in middle
aged subjects and it is possible that the effects of
aging on the lower airways may be greater in
elderly people.
Secondly, the diagnosis of sleep apnea in our
population was made with cardiorespiratory sleep
studies from a commercial system, instead of full
polysomnography. Such studies are an acceptable
alternative to polysomnography in subjects with
high pretest probability for sleep apnea,33 as was
the case in the population referred to our sleep
laboratory. Additionally, the therapeutic levels of
CPAP were determined in a titration study with the
AutoSet system. This system has been extensively
validated for CPAP titration in sleep apnea
patients9,19 and the use of auto-titrating CPAP
machines has been recently recommended.34
Furthermore, all the patients included in our study
were subsequently followed-up in our Sleep Clinic
and had tolerated well the prescribed CPAP levels
with significant improvement of their symptoms.
Thirdly, during the application of IPAP with the
BiPAP ventilator, a minimum mandatory pressure of
3.5–4 cm H2O was provided during expiration. In
both groups, the changes in end-expiratory lung
volume associated with the application of IPAP at
10 cm H2O were minimal (range 33–98ml), and
this suggests that this low level of expiratory
pressure applied did not influence significantly the
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K. Kostikas et al.1224reductions in UAR associated with the application
of IPAP in this study.
Finally, in the elderly the proportion of central
sleep apnea is likely to have been greater.2
However, in all of our patients the majority
(485%) of the apneas or hypopneas in the
diagnostic studies were obstructive, and thus we
are confident that central apneas were not a
confounding issue in this study.
Conclusions
We report that aging per se does influence the level
of CPAP that is required for the effective treatment
of sleep apnea, with elderly patients requiring
lower CPAP levels compared to young patients with
similar sleep apnea severity and anthropometric
characteristics. The application of CPAP is asso-
ciated with a reduction in UAR, which can be
attributed both to a direct ‘‘splinting’’ action of
CPAP on the upper airway during inspiration and to
an indirect impact of CPAP-induced lung inflation.
Both these actions are greater in the elderly apneic
patients. Therefore, we believe that aging should
be taken into account when prescribing of the
optimal therapeutic level of CPAP in clinical
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